MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.

MLA

Kanno, Shinichi, et al. “MicroRNA-196b Is an Independent Prognostic Biomarker in Patients with Pancreatic Cancer.” Carcinogenesis, vol. 38, no. 4, Apr. 2017, pp. 425–31. EBSCOhost, https://doi.org/10.1093/carcin/bgx013.

APA

Kanno, S., Nosho, K., Ishigami, K., Yamamoto, I., Koide, H., Kurihara, H., Mitsuhashi, K., Shitani, M., Motoya, M., Sasaki, S., Tanuma, T., Maguchi, H., Hasegawa, T., Kimura, Y., Takemasa, I., Shinomura, Y., & Nakase, H. (2017). MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer. Carcinogenesis, 38(4), 425–431. https://doi.org/10.1093/carcin/bgx013

Chicago

Kanno, Shinichi, Katsuhiko Nosho, Keisuke Ishigami, Itaru Yamamoto, Hideyuki Koide, Hiroyoshi Kurihara, Kei Mitsuhashi, et al. 2017. “MicroRNA-196b Is an Independent Prognostic Biomarker in Patients with Pancreatic Cancer.” Carcinogenesis 38 (4): 425–31. doi:10.1093/carcin/bgx013.